30.01.2013 Views

2009 Annual Report - CRH

2009 Annual Report - CRH

2009 Annual Report - CRH

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Consolidated Statement of Cash Flows<br />

for the financial year ended 31st December <strong>2009</strong> <strong>2009</strong> 2008<br />

€m €m<br />

Notes<br />

Cash flows from operating activities<br />

Profit before tax 732 1,628<br />

Finance costs (net) 297 343<br />

Group share of associates' profit after tax (48) (61)<br />

Profit on disposal of non-current assets (26) (69)<br />

Group operating profit 955 1,841<br />

13 Depreciation charge (including impairments) 794 781<br />

7 Share-based payment expense 28 24<br />

14 Amortisation of intangible assets (including impairments) 54 43<br />

29 Amortisation of capital grants (2) (3)<br />

Other non-cash movements (37) (15)<br />

26 Net movement on provisions (41) (28)<br />

20 Decrease/(increase) in working capital 783 (57)<br />

Cash generated from operations 2,534 2,586<br />

Interest paid (including finance leases) (294) (371)<br />

Irish corporation tax paid (2) (18)<br />

Overseas corporation tax paid (102) (304)<br />

Net cash inflow from operating activities 2,136 1,893<br />

Cash flows from investing activities<br />

Inflows<br />

16 Proceeds from disposal of non-current assets 103 168<br />

Interest received 31 51<br />

29 Capital grants received - 4<br />

Dividends received from associates 38 42<br />

172 265<br />

Outflows<br />

13 Purchase of property, plant and equipment (532) (1,039)<br />

32 Acquisition of subsidiaries and joint ventures (174) (777)<br />

15 Investments in and advances to associates (235) (156)<br />

15 Advances to joint ventures and purchase of trade investments (9) (50)<br />

20 Increase in finance-related receivables (115) -<br />

20 Deferred and contingent acquisition consideration paid (37) (34)<br />

(1,102) (2,056)<br />

Net cash outflow from investing activities (930) (1,791)<br />

Cash flows from financing activities<br />

Inflows<br />

30 Proceeds from issue of shares (net) 1,237 6<br />

Proceeds from exercise of share options 60 31<br />

25 Decrease in liquid investments 65 175<br />

Increase in interest-bearing loans, borrowings and finance leases 757 1,382<br />

25 Net cash inflow arising from derivative financial instruments 16 -<br />

2,135 1,594<br />

Outflows<br />

Treasury/own shares purchased (2) (414)<br />

Repayment of interest-bearing loans, borrowings and finance leases (2,501) (1,024)<br />

25 Net cash outflow arising from derivative financial instruments - (100)<br />

11 Dividends paid to equity holders of the Company (238) (347)<br />

11 Dividends paid to minority interests (7) (5)<br />

(2,748) (1,890)<br />

Net cash outflow from financing activities (613) (296)<br />

Increase/(decrease) in cash and cash equivalents 593 (194)<br />

Reconciliation of opening to closing cash and cash equivalents<br />

25 Cash and cash equivalents at 1st January 799 1,006<br />

25 Translation adjustment (20) (13)<br />

Increase/(decrease) in cash and cash equivalents 593 (194)<br />

25 Cash and cash equivalents at 31st December 1,372 799<br />

A reconciliation of cash and cash equivalents to net debt is presented in note 25 to the financial statements.<br />

K. McGowan, M. Lee, Directors<br />

<strong>CRH</strong> 65

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!